Tien Hoang

Nhà nghiên cứu Hồ sơ 6/10

96 công bố · 3.727 trích dẫn · h-index 26

Thông tin

🏛️Nơi công tác: Trường Đại học Đà Lạt
🔬Lĩnh vực: Y - Dược
🆔ORCID: 0009-0002-4154-578X
✍️Hồ sơ chưa đầy đủ — bổ sung thông tin

Chỉ số h-index 26 xếp học giả này vào lĩnh vực Y - Dược, thuộc nhóm 5% dẫn đầu trong 6.619 hồ sơ cùng lĩnh vực của danh bạ này.

Công bố tiêu biểu

Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial615 trích dẫn
Journal of Thoracic Oncology · 2020 · DOI

Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial467 trích dẫn
Journal of Thoracic Oncology · 2020 · DOI

Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised, double-blind, placebo-controlled, phase 3 trial347 trích dẫn
The Lancet Oncology · 2017 · DOI

Clinical Model to Predict Survival in Chemonaive Patients With Advanced Non–Small-Cell Lung Cancer Treated With Third-Generation Chemotherapy Regimens Based on Eastern Cooperative Oncology Group Data265 trích dẫn
Journal of Clinical Oncology · 2004 · DOI

IMpower131: Primary PFS and safety analysis of a randomized phase III study of atezolizumab + carboplatin + paclitaxel or nab-paclitaxel vs carboplatin + nab-paclitaxel as 1L therapy in advanced squamous NSCLC.220 trích dẫn
Journal of Clinical Oncology · 2018 · DOI

Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck147 trích dẫn
Annals of Oncology · 2012 · DOI

Phase III, randomized, double-blind, multicenter, placebo (P)-controlled trial of rilotumumab (R) plus epirubicin, cisplatin and capecitabine (ECX) as first-line therapy in patients (pts) with advanced MET-positive (pos) gastric or gastroesophageal junction (G/GEJ) cancer: RILOMET-1 study.144 trích dẫn
Journal of Clinical Oncology · 2015 · DOI

SKYSCRAPER-02: Tiragolumab in Combination With Atezolizumab Plus Chemotherapy in Untreated Extensive-Stage Small-Cell Lung Cancer121 trích dẫn
Journal of Clinical Oncology · 2023 · DOI

OA05.07 IMpower132: PFS and Safety Results with 1L Atezolizumab + Carboplatin/Cisplatin + Pemetrexed in Stage IV Non-Squamous NSCLC120 trích dẫn
Journal of Thoracic Oncology · 2018 · DOI

Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer89 trích dẫn
Lung Cancer · 2008 · DOI

Về lĩnh vực Y - Dược

6.619học giả

91.896công bố

2.589.484trích dẫn

4.2h-index trung bình

Hướng nghiên cứu phổ biến trong lĩnh vực:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Nơi có nhiều học giả lĩnh vực này nhất: